Ignite Creation Date:
2025-12-25 @ 12:59 AM
Ignite Modification Date:
2025-12-25 @ 11:12 PM
Study NCT ID:
NCT00306293
Status:
COMPLETED
Last Update Posted:
2018-03-23
First Post:
2006-03-21
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-02-20
Start Date Type:
ACTUAL
Primary Completion Date:
2006-11-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-11-27
Completion Date Type:
ACTUAL
First Submit Date:
2006-03-21
First Submit QC Date:
None
Study First Post Date:
2006-03-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-04-14
Results First Submit QC Date:
None
Results First Post Date:
2018-03-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-28
Last Update Post Date:
2018-03-23
Last Update Post Date Type:
ACTUAL